Feb 01, 2018

F. Hoffmann-La Roche Announces Financial Results for Fiscal 2017

Name of listed company: Chugai Pharmaceutical Co., Ltd.
Code number: 4519 (1st Section of Tokyo Stock Exchange)
Head office: 1-1, Nihonbashi-Muromachi 2-Chome, Chuo-ku, Tokyo
Chairman & CEO: Osamu Nagayama
Inquiries to: Masahiko Uchida,
General Manager, Corporate Communications Dept.
Tel:+81-(0)3-3273-0881

F. Hoffmann-La Roche Ltd. (hereafter “Roche”) [Head Office: Basel, Switzerland. CEO: Severin Schwan] announced today its financial results for fiscal 2017 (January 1 – December 31, 2017).
Roche owns 59.89% of Chugai's outstanding shares (61.30% of the total number of shares issued excluding treasury stock) as of end of December 2017.
Its press release and presentation materials can be found on its website (https://www.roche.com).
Chugai’s performance for the period of January 1 to December 31, 2017 is included in the announced Roche Group’s results.

Media Releases Investor Updates Presentation Annual Report
  • Like
  • Tweet
  • LINE it!
  • E-mail
Back to top